Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency is a rare genetic condition that causes very low neutrophil counts from birth. People with this condition have frequent, severe infections, mouth ulcers, and fevers, and doctors describe this as chronic neutropenia. It is lifelong, but the pattern and severity can vary between children and adults. Treatment often includes daily granulocyte colony-stimulating factor (G‑CSF) injections and prompt antibiotics for infections, and stem cell transplant may be considered in severe cases. The outlook depends on infection control and response to therapy, and many living with Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency do well with careful, ongoing care.
Overview
Autosomal recessive severe congenital neutropenia due to cxcr2 deficiencySymptoms
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency usually shows up in early infancy with recurrent fevers and bacterial infections. Early signs include mouth ulcers, gum inflammation, skin or umbilical infections, and pneumonia. Doctors often find low neutrophil counts.
Outlook and prognosis
Most people with autosomal recessive severe congenital neutropenia due to CXCR2 deficiency need lifelong care to prevent and treat infections. With early diagnosis, infection precautions, and tailored therapies, many achieve good growth and attend school and work. Regular specialist follow-up guides treatment as needs change.
Causes and risk factors
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency stems from inheriting two nonworking CXCR2 variants. Risk rises when both parents are carriers, especially with consanguinity or family history. Environment doesn’t cause it, though infections and malnutrition can worsen complications.
Genetic influences
Genetics are central in autosomal recessive severe congenital neutropenia due to CXCR2 deficiency. Two altered CXCR2 gene copies are needed, typically inherited from carrier parents. Variations in CXCR2 affect neutrophil development and trafficking, shaping severity, infection risk, and family recurrence.
Diagnosis
Doctors suspect autosomal recessive severe congenital neutropenia due to CXCR2 deficiency when infants have recurrent infections and persistently very low neutrophils. Diagnosis of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency relies on clinical features, repeated blood counts, and confirmation with genetic tests identifying CXCR2 variants.
Treatment and drugs
Treatment for autosomal recessive severe congenital neutropenia due to CXCR2 deficiency often includes daily granulocyte colony–stimulating factor (G‑CSF) to raise neutrophils and lower infection risk. Many also need prompt antibiotics for infections and careful dental/skin care. In select cases, hematopoietic stem cell transplant may be considered when response is limited or complications occur.
Symptoms
For many families, daily life with a newborn or toddler includes infections that seem to come one after another—ears, chest, skin, or mouth. Early on, this might look like fevers that return, painful mouth sores, or skin spots that get tender and swollen. Parents may notice early features of Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency, such as infections that keep coming back and infections that don’t make much pus. Doctors often find very low neutrophil levels on a blood test, which helps explain why bacterial infections take hold so easily.
Infections often begin in the first months of life and may affect the skin, mouth, ears, sinuses, or lungs. In severe congenital neutropenia, they can clear with antibiotics but tend to come back.
Fevers may be the first or only sign of infection, sometimes without a clear source. They often return soon after finishing antibiotics.
Painful mouth ulcers and swollen, bleeding gums are common and can make feeding, brushing teeth, or talking uncomfortable. Gum disease can develop if these infections keep recurring.
Tender red bumps or boils can form, especially in the diaper area or around hair follicles. There may be little or no pus even with a significant infection.
How people usually first notice Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency?
Parents and doctors often first notice something is off in the first weeks to months of life when a baby has repeated bacterial infections—such as skin infections, umbilical stump infections, mouth sores, or pneumonia—that seem unusually frequent or severe. Blood tests done because of these infections show very low neutrophil counts (a type of white blood cell), pointing to severe congenital neutropenia; this pattern raises concern for a genetic cause like CXCR2 deficiency. In practice, the first signs of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency are recurrent, hard‑to‑shake infections early in infancy and persistently low neutrophils on testing, which is how the condition is first noticed.
Types of Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency is a rare inherited immune disorder. Variants of this condition are defined by the specific CXCR2 gene changes and how much receptor function remains, which can shape infection risk and severity over time. Not everyone will experience every type.
Classic biallelic loss
Both CXCR2 copies carry loss-of-function changes. This typically causes very low neutrophil counts from infancy with frequent bacterial skin, mouth, and lung infections. Growth and development are often normal between infections.
Hypomorphic variants
CXCR2 changes reduce but do not eliminate receptor function. Infections still occur but may be less frequent or severe, and neutrophil counts can be higher than in the classic form. The balance of symptoms can shift over time.
Genotype with residual signaling
Certain missense variants allow partial signaling. People with this type of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency may have milder, fluctuating neutropenia and fewer hospitalizations. Early symptoms of CXCR2-related neutropenia can include mouth ulcers, slow-healing skin infections, or recurrent ear infections.
What genetics can tell you about symptoms
Babies with CXCR2-related severe congenital neutropenia often have repeated bacterial infections, mouth ulcers, poor wound healing, and fevers because too few mature neutrophils reach the bloodstream. CXCR2 variants disrupt chemokine signaling, so white cells don’t develop or move properly to fight germs.
Causes and risk factors
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency happens when a child inherits two nonworking copies of the CXCR2 gene. Parents are usually healthy carriers who each have one altered copy, and being related increases the chance they carry the same change. When both parents are carriers, each pregnancy has a 25% chance of an affected child. Environmental risk factors for autosomal recessive severe congenital neutropenia due to CXCR2 deficiency include crowded settings and frequent germ exposure, which increase infections but do not cause the condition. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Planning a pregnancy or awaiting results can raise questions about what influences rare conditions present at birth. Questions often arise even before early symptoms of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency are recognized. Doctors often group risks into internal (biological) and external (environmental). For this condition, only a few non-genetic patterns have been studied, and many exposures show no clear link.
Older maternal or paternal age has not been shown to increase the likelihood of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency. Available data do not demonstrate a consistent association.
Common conditions in pregnancy, such as diabetes or thyroid disease, are not known to raise the chance of this diagnosis. Current evidence does not link these health issues to this congenital neutropenia.
Certain infections can affect fetal development, but no specific infection has been tied to this condition. Routine prenatal prevention and vaccination remain important for overall pregnancy health.
High-dose ionizing radiation has not been shown to specifically increase the chance of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency. Evidence for a direct link is lacking.
Genetic risk factors
Across families, the key genetic driver is inheriting two nonworking copies of the CXCR2 gene—one from each parent. When discussing the genetic causes of autosomal recessive severe congenital neutropenia due to cxcr2 deficiency, the main risk is being born to two carrier parents. Some risk factors are inherited through our genes. Carriers usually stay healthy, but they can pass the altered gene to their children.
Biallelic CXCR2 changes: The condition results from harmful changes in both copies of the CXCR2 gene. One altered copy alone usually means someone is a healthy carrier.
Autosomal recessive inheritance: This follows an autosomal recessive pattern, so two nonworking copies are needed for the condition to appear. It is not linked to sex chromosomes, and all sexes are affected at similar rates.
Carrier couple risk: When both parents carry a CXCR2 change, each pregnancy has a 25% (1 in 4) chance of a child with the condition. There is also a 50% (1 in 2) chance of a carrier child and a 25% chance of a child without the change.
Sibling recurrence: Once one child is diagnosed, each brother or sister has a 25% (1 in 4) chance of also being affected. Each sibling also has a 50% (1 in 2) chance to be a carrier.
Consanguinity factor: Parents who are blood relatives have a higher chance of sharing the same rare CXCR2 change. This increases the likelihood of an affected child.
Variant combinations: The two CXCR2 changes can be the same from both parents or two different changes. Either combination can disrupt CXCR2 enough to cause severe congenital neutropenia.
Variable expression: Different CXCR2 changes may influence how severe the neutropenia is or when it first shows. Risk is not destiny—it varies widely between individuals.
Lifestyle risk factors
Daily habits don’t cause autosomal recessive severe congenital neutropenia due to cxcr2 deficiency, but they can influence infection risk, healing, and daily functioning. The points below focus on how lifestyle affects autosomal recessive severe congenital neutropenia due to cxcr2 deficiency and can complement your medical care. Choices around food, hygiene, activity, sleep, and substances can help reduce complications.
Choose thoroughly cooked foods and avoid unpasteurized dairy, raw eggs, and undercooked meats to cut bacterial exposure that neutropenia makes dangerous. Careful washing, peeling, and refrigeration lowers gastrointestinal infection risk.
Adequate protein and micronutrients (zinc, vitamin C, folate, and B12) support skin and mucosal barriers and wound healing even if neutrophil counts stay low. Undernutrition can increase mouth sores, poor healing, and infection severity.
Twice-daily brushing, gentle flossing, and antiseptic mouthwash decrease gingivitis and mouth ulcers that often complicate severe neutropenia. Regular dental checkups with preventive cleanings reduce dental infection flares.
Daily moisturizing, not picking at skin, and careful nail trimming reduce cracks and hangnails that can become cellulitis or paronychia. Clean and cover minor cuts promptly to limit bacterial entry.
Risk prevention
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency can’t be prevented at the gene level, but you can lower infection risks and catch problems early. Day to day, the goal is to reduce germs, act fast with fevers, and keep close follow-up with your care team. Prevention works best when combined with regular check-ups. Plans are tailored with your specialist based on your blood counts, infection history, and treatments.
Know the early symptoms of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency—fever, mouth ulcers, sore throat, skin redness—and seek urgent care for any fever. Have a written plan for when to call, go to the ER, and start antibiotics if prescribed. Keep a thermometer at home and check temperatures promptly.
Keep routine vaccines current to lower the chance of preventable infections. Most vaccines are safe with neutropenia, but discuss live vaccines with your specialist. Household members should also be fully vaccinated to create a protective buffer.
Frequent handwashing, regular showers, and gentle skin care lower bacterial exposure. Clean cuts right away and use topical antiseptics if advised. Change toothbrushes regularly and avoid sharing personal items like razors.
Brush twice daily with a soft brush and floss carefully to reduce gum infections. See a dentist regularly and treat mouth sores early. Ask about antimicrobial mouth rinses during high‑risk periods.
Transmission
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency is not contagious and cannot be “caught” from someone else. It happens because of changes in the CXCR2 gene and is passed down in an autosomal recessive way, usually when both parents are healthy carriers.
When two carriers have a child, each pregnancy has a 25% chance the child will have the condition, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither changed copy. People living with this neutropenia will pass one changed copy to all of their children; if their partner is not a carrier, all children will be carriers only, but if the partner is a carrier, each child has a 50% chance to be affected. This explains how Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency is inherited and reflects the genetic transmission of Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency.
When to test your genes
Consider genetic testing if you or a sibling had severe, early-life neutropenia, frequent serious infections, or dangerously low neutrophil counts unexplained by other causes. Testing is also appropriate before pregnancy or during family planning if there’s a known CXCR2 variant in relatives. Confirmed diagnosis guides infection prevention, G-CSF decisions, and tailored monitoring.
Diagnosis
Frequent fevers, skin infections that don’t clear easily, or mouth sores in early infancy often prompt the first medical visit. Doctors usually begin by listening to the story of infections and checking blood counts over time. For Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency, diagnosis typically combines clinical features with targeted lab tests to confirm the cause. The goal is to show whether neutrophil numbers are persistently very low and to identify the underlying genetic change.
Clinicians look for infections starting in the newborn period, slow-to-heal wounds, mouth ulcers, and signs of inflammation. Patterns like repeated bacterial infections and hospitalizations raise suspicion for severe congenital neutropenia.
Repeated blood tests show persistently low absolute neutrophil counts, often below 0.5 × 10^9/L (below 500/µL). Other white blood cell types and platelets may be normal, which helps narrow the cause.
Counts are measured several times per week over 6–8 weeks. This helps confirm persistent severe neutropenia and distinguish it from cyclic neutropenia, which rises and falls in a set pattern.
A sample from the hip bone is checked for how neutrophil precursors mature. Many with severe congenital neutropenia show a “maturation arrest,” meaning cells stall before becoming mature neutrophils.
Stages of Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency does not have defined progression stages. It’s present from birth and tends to follow a lifelong pattern, with infection risk changing with treatment and day‑to‑day exposures rather than moving through set phases. Doctors often consider early symptoms of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency—such as frequent fevers, mouth sores, and repeated skin or lung infections—alongside very low neutrophil counts on blood tests; Different tests may be suggested to help confirm the cause, including genetic testing for changes in the CXCR2 gene. Ongoing care usually includes regular blood counts (CBCs) and tracking infections to see how stable things are and how well medicines like G‑CSF are working.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after learning about Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency. Day to day, this condition often means frequent infections early in life, hospital visits for fevers, and careful monitoring. With ongoing care, many people maintain safer white blood cell levels and reduce infections, but risks don’t disappear. Doctors call this the prognosis—a medical word for likely outcomes.
Here’s what research and experience suggest about the future. Early symptoms of Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency usually appear in infancy or early childhood, and infection risk is highest then. Over time, some children respond well to medicines that boost neutrophils, which can lower the rate of serious infections and improve growth and school attendance. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
The outlook is not the same for everyone, but children who reach stable neutrophil counts and have rapid treatment for infections tend to do better. Life expectancy can be near typical when infections are prevented and managed quickly; most reported deaths relate to overwhelming infections, especially early on or when treatment is delayed. Unlike some other forms of severe congenital neutropenia, the risk of blood cancers appears lower with CXCR2-related disease, though long-term data are limited, so regular checks remain important. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Living day to day, people with autosomal recessive severe congenital neutropenia due to CXCR2 deficiency often face repeated, sometimes serious infections that can leave lasting marks on health. Over time, these infections can affect the lungs, skin, teeth, and overall energy, with patterns that differ from one person to the next. Long-term effects vary widely, and some change across childhood and adulthood. Early signs of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency often appear in infancy, which helps explain why the long-term picture can start early in life.
Serious bacterial infections can continue over many years, often starting in infancy. Common sites include the lungs, skin, mouth, and deep tissues.
Repeated pneumonias can lead to lasting airway damage (bronchiectasis) with chronic cough and breathlessness. For some, this causes exercise limits in later childhood or adulthood.
Chronic mouth ulcers, gum disease, and skin abscesses can recur and leave scarring. Dental problems may build up over time due to repeated infections.
A subset develop bone marrow problems such as myelodysplastic syndrome or acute myeloid leukemia over the years. Doctors may track these changes over years to see whether the risk is rising.
How is it to live with Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency?
Daily life with autosomal recessive severe congenital neutropenia due to CXCR2 deficiency often revolves around preventing and managing infections, because the body’s frontline white blood cells are low in number or can’t reach sites of infection efficiently. For many, this means frequent checkups, prompt attention to fevers, careful hygiene, and sometimes limits on crowded settings, while still finding ways to keep school, work, and social life as normal as possible. Family members and close friends often become vigilant partners—helping notice early signs of illness, supporting treatment routines, and balancing protection with the need for everyday experiences. Over time, people build confidence with clear action plans, vaccinations as advised, and guidance from their care team, which helps reduce anxiety and keeps life moving forward.
Treatment and drugs
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency is treated with the goal of raising infection‑fighting white cells (neutrophils), preventing infections, and managing complications. Daily or near‑daily injections of granulocyte colony‑stimulating factor (G‑CSF) are often the first step to boost neutrophil counts and lower the risk of serious infections; a doctor may adjust your dose to balance benefits and side effects. Alongside medical treatment, lifestyle choices play a role, including prompt care for fevers, up‑to‑date vaccines (non‑live when counts are very low), regular dental care, and preventive antibiotics in select situations based on your specialist’s advice. If G‑CSF doesn’t achieve safe counts or causes problems, a stem cell (bone marrow) transplant may be considered, which is currently the only treatment with curative potential but carries short‑ and long‑term risks that require careful counseling. Supportive care can make a real difference in how you feel day to day, so keep close follow‑up with your care team and seek urgent medical attention for any fever or signs of infection.
Non-drug treatment
Living with Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency often means a higher risk of infections, so daily routines that lower exposure and catch problems early matter. Alongside medicines, non-drug therapies can make day-to-day life safer and more predictable. Plans for urgent care and procedures like stem cell transplant may be part of care in select cases. Support for teeth, skin, and nutrition helps protect the body’s barriers and recovery.
Wash hands regularly and teach close contacts to do the same. Clean cuts right away and cover them until healed. Avoid sharing razors, towels, or toothbrushes.
Keep a clear plan for what to do if a fever or new chills start, including when to call or go in. Recognizing early symptoms of autosomal recessive severe congenital neutropenia complications—like fever, mouth sores, or skin redness—can speed care. Have a thermometer and clinic numbers easy to reach.
Brush gently twice a day with a soft brush and floss as advised to lower gum infections. See a dentist familiar with low white blood cell counts for regular cleanings. Treat mouth sores early to keep eating and drinking comfortable.
Moisturize dry skin to prevent cracks where germs can enter. Keep nails short and avoid cuticle cutting. Use gloves for yardwork or cleaning to prevent scrapes.
Your genes may have an impact on how drugs work for you
For people with autosomal recessive severe congenital neutropenia due to CXCR2 deficiency, gene changes can alter how well drugs boost neutrophils or how the body responds to infections. Pharmacogenetic testing and close monitoring help tailor treatments and doses for safer, better results.
Pharmacological treatments
Treatment for autosomal recessive severe congenital neutropenia due to CXCR2 deficiency centers on raising neutrophil counts and preventing infections you can feel day to day. First-line medications are those doctors usually try first, based on safety, effectiveness, and long experience in similar neutropenia conditions. Plans are tailored because not everyone responds to the same medication in the same way. Care teams also use preventive antibiotics or antifungals when infections recur, even when early symptoms of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency are subtle.
A daily or near-daily injection that stimulates the bone marrow to release more neutrophils. Dosing may be increased or lowered gradually to find the lowest dose that keeps counts safe.
A longer-acting form of G-CSF given less often, which some find easier to keep up with. It may be used once stable on filgrastim or when fewer injections are preferred.
Another G-CSF option used in many countries, similar in effect to filgrastim. Doctors choose among G-CSF brands based on availability, prior response, and tolerance.
An alternative growth factor sometimes tried if response to G-CSF is limited. It can raise white blood cells but may not boost neutrophils as reliably as G-CSF.
Genetic influences
This condition is driven by inherited changes in a gene called CXCR2, which helps certain white blood cells (neutrophils) move to where they’re needed. When CXCR2 doesn’t work properly, neutrophils often stay low in the bloodstream from birth. In an autosomal recessive pattern, a child must receive a nonworking copy of CXCR2 from both biological parents to develop autosomal recessive severe congenital neutropenia due to CXCR2 deficiency. Parents typically feel well; a “carrier” means you hold the gene change but may not show symptoms. When two carriers have a child, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier, and a 25% chance of neither. The severity of infections and low counts can differ between people in the same family, because other genes and health factors can modify how the condition shows up. Genetic testing for autosomal recessive severe congenital neutropenia due to CXCR2 deficiency can confirm the diagnosis, clarify carrier status for relatives, and guide family planning or donor choices.
Is Autosomal recessive severe congenital neutropenia due to cxcr2 deficiency genetic?
Genetics are central in autosomal recessive severe congenital neutropenia due to CXCR2 deficiency. Two altered CXCR2 gene copies are needed, typically inherited from carrier parents. Variations in CXCR2 affect neutrophil development and trafficking, shaping severity, infection risk, and family recurrence.
Pharmacogenetics—how genetics influence drug effects
Because the CXCR2 gene change affects how neutrophils mature and move, it can shape how well certain medicines work to raise white blood cell levels. Granulocyte colony‑stimulating factor (G‑CSF), a common first‑line treatment, may help, but in some people with autosomal recessive severe congenital neutropenia due to CXCR2 deficiency the rise in counts is limited or requires higher doses, so doctors track blood tests closely and adjust the plan. Knowing the exact gene involved helps your team set expectations for G‑CSF dosing, plan infection prevention, and discuss earlier whether a stem cell transplant should be considered if medicines don’t restore safe neutrophil levels. Not every difference in response is genetic, but your CXCR2 result gives useful clues that guide dosing, lab follow‑up, and when to change course. Antibiotics and antifungals used to prevent or treat infections generally follow standard dosing based on age, kidney and liver function, and body size, rather than this gene. In practice, pharmacogenetic testing for autosomal recessive severe congenital neutropenia due to CXCR2 deficiency mainly confirms the diagnosis and informs care, helping avoid prolonged trial‑and‑error with treatments unlikely to address the underlying pathway.
Interactions with other conditions
Other illnesses can change how well your body handles infections when you’re living with Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency. Doctors call it a “comorbidity” when two conditions occur together. Common viral infections like colds or flu can set the stage for tougher bacterial problems—ear infections that don’t clear, chest infections that linger, or skin infections that spread—because neutrophils (a key infection‑fighting white blood cell) are very low. Ongoing gum disease or chronic sinus and lung problems can also feed into a cycle of repeated infections; once these take hold, they often make future infections more likely. Autoimmune conditions and treatments that suppress the immune system, such as long courses of steroids, may further lower infection defenses, so flares of those conditions can make this neutropenia harder to manage. Early symptoms of Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency can look like routine viral bugs at first, so coordinating care between your primary doctor, dentist, and specialists helps catch overlaps and prevent complications.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of newborns who seemed healthy at birth but soon faced repeated, hard‑to-clear infections. In some families, several siblings were affected while parents and older relatives stayed well, a clue that the condition followed a hidden, recessive pattern. Doctors saw babies with fevers that kept returning, mouth sores that wouldn’t heal, or deep skin infections from minor scrapes. Over time, these everyday observations pushed clinicians to look more closely at the white blood cells that fight bacteria.
First described in the medical literature as a form of “severe congenital neutropenia,” the condition was initially grouped with other causes of very low neutrophil counts present from birth. Early reports focused on symptoms and infection patterns because the exact cause was unknown. Blood tests showed almost no neutrophils circulating, yet the bone marrow held immature cells that didn’t mature properly. This mismatch suggested a disrupted signal guiding young cells to become infection‑fighting neutrophils and move where they were needed.
As medical science evolved, researchers began sorting congenital neutropenia into subtypes based on underlying pathways. Clues came from how cells moved and responded to chemical signals. CXCR2, a receptor on developing and mature white cells, emerged as a key “homing” and activation switch. When this switch is missing or not working, neutrophils may be scarce in the bloodstream or fail to reach infected tissues, leaving people vulnerable despite otherwise normal growth and development.
Advances in genetics confirmed that, in some families, autosomal recessive severe congenital neutropenia was due to changes in the CXCR2 gene. This explained why unaffected parents could have more than one child with the condition, and why brothers and sisters sometimes shared similar early symptoms of CXCR2‑related neutropenia while other relatives remained healthy carriers. Genetic testing shifted the diagnosis from a broad label to a precise cause, allowing clearer counseling about recurrence risk and options for family planning.
From early theories to modern research, the story of autosomal recessive severe congenital neutropenia due to CXCR2 deficiency moved from bedside observations to targeted molecular answers. Not every early description was complete, yet together they built the foundation of today’s knowledge. With identification of CXCR2 deficiency, care teams could better tailor monitoring, infection prevention, and discussions about treatments that support neutrophil numbers and function. The history continues to evolve as registries and international collaborations collect long‑term outcomes, helping refine when to screen siblings, how to time vaccinations and antibiotics, and which therapies offer the most benefit over a lifetime.